• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌同时性腹膜播散的预后及治疗策略

Prognoses and treatment strategies for synchronous peritoneal dissemination of colorectal carcinoma.

作者信息

Sato Harunobu, Toyama Kunihiro, Koide Yoshikazu, Ozeki Shinji, Hatta Kouhei, Maeda Kotaro

机构信息

Department of Surgery, Fujita Health University, School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

出版信息

Surg Today. 2016 Jul;46(7):860-71. doi: 10.1007/s00595-015-1254-8. Epub 2015 Oct 3.

DOI:10.1007/s00595-015-1254-8
PMID:26433728
Abstract

PURPOSE

We devised a simple dichotomous classification system and showed sufficient reproducibility to indicate treatment strategies for peritoneal metastasis of colorectal cancer.

METHODS

We included 67 patients with peritoneal metastasis of colorectal cancer and classified them according to the largest lesion size, number of lesions and number of regional peritoneal metastases. The oncological data were recorded and compared.

RESULTS

According to the univariate analyses, the prognoses were significantly better in patients with ≤3 disseminated lesions than in those with ≥4, and in patients with disseminated lesions in only one region than in those with ≥2 lesions. A multivariate analysis showed that primary tumor resection and the presence of peritoneal metastases in only one region were favorable factors for the patient survival. Patients with disseminated lesions in only one region (localized group) and those with nonlocalized lesions had three-year survival rates of 45.6 and 12.2 %, respectively. Finally, primary tumor resection improved the prognoses in both the localized and nonlocalized groups.

CONCLUSIONS

Colorectal cancer patients were categorized into localized and nonlocalized groups according to the number of regions with peritoneal metastasis, and significant prognostic associations were demonstrated. Subsequent analyses of the oncological data suggested that primary tumor resection contributes to an improved prognosis in all patients with synchronous peritoneal metastases.

摘要

目的

我们设计了一种简单的二分法分类系统,并显示出足够的可重复性,以指导结直肠癌腹膜转移的治疗策略。

方法

我们纳入了67例结直肠癌腹膜转移患者,并根据最大病灶大小、病灶数量和区域腹膜转移数量对他们进行分类。记录并比较肿瘤学数据。

结果

根据单因素分析,≤3个播散性病灶的患者预后明显好于≥4个病灶的患者,仅一个区域有播散性病灶的患者预后明显好于≥2个病灶的患者。多因素分析表明,原发肿瘤切除和仅一个区域存在腹膜转移是患者生存的有利因素。仅一个区域有播散性病灶的患者(局限组)和非局限组患者的三年生存率分别为45.6%和12.2%。最后,原发肿瘤切除改善了局限组和非局限组的预后。

结论

根据腹膜转移区域的数量,将结直肠癌患者分为局限组和非局限组,并证明了显著的预后相关性。随后对肿瘤学数据的分析表明,原发肿瘤切除有助于改善所有同步性腹膜转移患者的预后。

相似文献

1
Prognoses and treatment strategies for synchronous peritoneal dissemination of colorectal carcinoma.结直肠癌同时性腹膜播散的预后及治疗策略
Surg Today. 2016 Jul;46(7):860-71. doi: 10.1007/s00595-015-1254-8. Epub 2015 Oct 3.
2
The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.姑息性切除在无法切除的IV期结直肠癌患者中对无症状原发性肿瘤的作用。
Dis Colon Rectum. 2014 Sep;57(9):1049-58. doi: 10.1097/DCR.0000000000000193.
3
[Surgical outcomes and prognostic factors of primary colorectal cancer with peritoneal dissemination].
Gan To Kagaku Ryoho. 2013 Nov;40(12):2044-6.
4
Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study.R0切除的IV期结直肠癌患者腹膜转移的预后意义:一项多中心回顾性研究
Dis Colon Rectum. 2017 Oct;60(10):1041-1049. doi: 10.1097/DCR.0000000000000858.
5
Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.手术治疗合并腹膜转移的 IV 期结直肠癌的临床获益。
J Gastroenterol. 2014 Apr;49(4):646-54. doi: 10.1007/s00535-013-0820-3. Epub 2013 Jun 24.
6
Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status).基于无残留病灶(R0 状态)的 IV 期结直肠癌患者腹膜播散的病理发现进行预后预测。
Surg Today. 2019 Sep;49(9):755-761. doi: 10.1007/s00595-019-01800-1. Epub 2019 Apr 8.
7
[Clinicopathologic characteristics and postoperative prognosis in colorectal cancer with peritoneal dissemination].[结直肠癌腹膜播散的临床病理特征及术后预后]
Zhonghua Wai Ke Za Zhi. 2008 Nov 1;46(21):1634-7.
8
Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.结直肠癌伴腹膜转移行肉眼下肿瘤完全切除的临床影响。
Surgery. 2012 Feb;151(2):238-44. doi: 10.1016/j.surg.2010.10.018. Epub 2010 Dec 22.
9
Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.结直肠癌同时合并腹膜转移和肝转移患者的发病率、预后和治疗选择。
Dis Colon Rectum. 2013 Dec;56(12):1373-80. doi: 10.1097/DCR.0b013e3182a62d9d.
10
New Staging System for Colorectal Cancer Patients with Synchronous Peritoneal Metastasis in Accordance with the Japanese Classification of Colorectal Carcinoma: A Multi-Institutional Study.依据日本结直肠癌分类的同步性腹膜转移结直肠癌患者新分期系统:一项多机构研究
Dig Surg. 2016;33(1):66-73. doi: 10.1159/000442027. Epub 2015 Dec 1.

引用本文的文献

1
Visceral adipose tissue is associated with occult synchronous peritoneal metastasis in colorectal cancer.内脏脂肪组织与结直肠癌隐匿性同步腹膜转移相关。
Pleura Peritoneum. 2025 Apr 24;10(2):81-88. doi: 10.1515/pp-2024-0030. eCollection 2025 Jun.
2
CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer.CILP2 是结直肠癌腹膜转移预测和治疗靶点的潜在生物标志物。
Sci Rep. 2024 May 31;14(1):12487. doi: 10.1038/s41598-024-63366-4.
3
Risk Factors for Synchronous Peritoneal Metastases in Colorectal Cancer: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer.同步性转移性结直肠癌原发肿瘤切除必要性的评估
Surg Today. 2014 Dec;44(12):2287-92. doi: 10.1007/s00595-014-0869-5. Epub 2014 Mar 14.
2
Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database.结直肠癌腹膜转移的预后因素:一项对来自多机构数据库的921例患者的分析
Surg Today. 2014 Sep;44(9):1643-50. doi: 10.1007/s00595-013-0735-x.
3
Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.
结直肠癌同步腹膜转移的危险因素:系统评价与Meta分析
Front Oncol. 2022 Jun 20;12:885504. doi: 10.3389/fonc.2022.885504. eCollection 2022.
4
Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis.同步性腹膜转移结直肠癌患者预后列线图的开发与验证
Front Oncol. 2021 Jul 1;11:615321. doi: 10.3389/fonc.2021.615321. eCollection 2021.
5
A rare sporadic pancreatic desmoid fibromatosis with splenic vein invasion diagnosed by CT scan-guided core needle biopsy: a case report with possible differential diagnosis from metastatic colorectal or renal cancer.经CT扫描引导下粗针穿刺活检诊断的罕见散发性胰腺韧带样纤维瘤病伴脾静脉侵犯:1例报告及与转移性结直肠癌或肾癌的鉴别诊断探讨
J Surg Case Rep. 2021 Jun 26;2021(6):rjab257. doi: 10.1093/jscr/rjab257. eCollection 2021 Jun.
6
Multiple peritoneal dissemination of T2 colorectal cancer without lymph node metastases: a case report.无淋巴结转移的T2期结直肠癌多发腹膜播散:一例报告
J Surg Case Rep. 2020 Jul 31;2020(7):rjaa118. doi: 10.1093/jscr/rjaa118. eCollection 2020 Jul.
手术治疗合并腹膜转移的 IV 期结直肠癌的临床获益。
J Gastroenterol. 2014 Apr;49(4):646-54. doi: 10.1007/s00535-013-0820-3. Epub 2013 Jun 24.
4
Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.多模式治疗晚期结直肠癌患者全身炎症反应的预后意义。
Oncology. 2013;84(2):100-7. doi: 10.1159/000343822. Epub 2012 Nov 9.
5
Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.评估一种基于炎症的预后评分系统,用于识别II期结直肠癌术后需要辅助化疗的患者。
Exp Ther Med. 2011 Jan;2(1):95-101. doi: 10.3892/etm.2010.175. Epub 2010 Dec 2.
6
Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.伴有和不伴有靶向治疗的结直肠癌伴腹膜转移患者的化疗结果。
Eur J Surg Oncol. 2012 Jul;38(7):617-23. doi: 10.1016/j.ejso.2012.03.008. Epub 2012 May 8.
7
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.采用全身化疗治疗结直肠腹膜癌转移:北中央癌症治疗组 N9741 和 N9841 三期临床试验的汇总分析。
J Clin Oncol. 2012 Jan 20;30(3):263-7. doi: 10.1200/JCO.2011.37.1039. Epub 2011 Dec 12.
8
Validation and clinical use of the Japanese classification of colorectal carcinomatosis: benefit of surgical cytoreduction even without hyperthermic intraperitoneal chemotherapy.日本结直肠肿瘤转移分类的验证和临床应用:即使没有腹腔内热化疗,手术减瘤也有益处。
Dig Surg. 2010;27(6):473-80. doi: 10.1159/000320460. Epub 2010 Nov 10.
9
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.细胞减灭术和腹腔内热灌注化疗联合全身化疗与单纯全身化疗治疗结直肠腹膜转移癌的比较。
Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.
10
Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon.原发性结肠癌所致同步性腹膜癌转移(PC)患者的预后因素
J Gastrointest Surg. 2009 Sep;13(9):1593-8. doi: 10.1007/s11605-009-0939-y. Epub 2009 Jun 2.